U.S. Banks Stock News

Why Coupang (CPNG) is back in focus for investors Coupang (CPNG) is back under the spotlight after confirming a massive data breach affecting over 33 million customers, along with fresh disclosures of additional compromised records and a wave of securities class action lawsuits. See our latest analysis for Coupang. The data breach, regulatory probe and cluster of class action filings appear to be weighing on sentiment. Coupang’s 30 day share price return shows a decline of 20.34% and its year...

ATRenew Inc. recently participated as the sole Chinese representative at Circular Markets London, outlining how its automated infrastructure supports standardized, compliant global supply chains for pre-owned electronics. The company used the forum to position itself as a key bridge between China’s vast device supply and international circular economy demand, highlighting its ambition to expand globally in pre-owned electronics. We’ll now examine how ATRenew’s push to connect China’s...

Packaging Corporation of America (PKG) is back in focus after missing fourth quarter earnings expectations, as mixed analyst reactions and talk of potential March price hikes intersect with questions about margins, volumes, and capital efficiency. See our latest analysis for Packaging Corporation of America. The recent earnings miss and talk of March price hikes come on the back of a strong run, with a 30 day share price return of 12.58% and a 1 year total shareholder return of 22.49%...

PepsiCo (NasdaqGS:PEP) is cutting prices on core snack brands such as Lay's, Doritos, Cheetos, and Tostitos to address affordability concerns and shifting consumer habits. The company is adjusting to changing demand patterns linked to weight loss drugs and growing interest in portion control, while also delaying parts of its net zero sustainability goals. Alongside pricing moves, PepsiCo is increasing its focus on digitalization, e-commerce engagement, and AI driven sustainable agriculture...

Trupanion (TRUP) is back in focus ahead of its earnings report after Thursday’s close, with investors weighing slower forecast revenue growth against the company’s record of topping Wall Street expectations. See our latest analysis for Trupanion. At a share price of US$32.33, Trupanion’s short term momentum has softened, with a 30 day share price return of 11.69% and a year to date share price return decline of 13.09%, adding to a 12 month total shareholder return decline of 30.22%, even as...

Old Second Bancorp (NasdaqGS:OSBC) has authorized a new share repurchase program of up to $43.9 million. The buyback authorization extends through 2026. The program adds another capital return tool alongside existing balance sheet and lending activities. Old Second Bancorp, the holding company for Old Second National Bank, operates as a regional banking provider focused on lending, deposits, and other financial services. For investors, a new repurchase authorization of this size can be an...

In December 2025, Red Cat Holdings, Inc. announced that a second Asia-Pacific ally had selected its NDAA-compliant Black Widow sUAS, with an undisclosed number of two-aircraft systems, ground control stations and mission components scheduled for delivery across 2026. This repeat win in the Asia-Pacific region underlines growing allied demand for Red Cat’s modular, tactical-edge ISR platforms as part of its broader Family of Systems offering. We’ll now consider how this additional...

If you are trying to figure out whether Clear Secure is attractively priced or already reflecting the story in its share price, you are in the right place. The stock recently closed at US$32.54, with a 2.4% gain over the last 7 days, a 7.0% decline over 30 days, a 5.4% decline year to date, and a 38.2% return over 1 year, while the 3 year return sits at 18.3%. These mixed short term moves alongside stronger 1 year performance have kept Clear Secure on many investors' watchlists, especially...

Recent performance snapshot Stoke Therapeutics (STOK) has drawn fresh attention after recent share price moves, with the stock showing a 1 day return of about a 1% decline, alongside modest gains over the past week. Investors are also weighing its roughly 10% return over the past month and about 24% over the past 3 months, compared with longer term figures and the company’s early stage biopharmaceutical profile. See our latest analysis for Stoke Therapeutics. Looking beyond the recent moves,...

American Superconductor (AMSC) is back in focus after reporting Q3 results that exceeded expectations, highlighting higher sales, sharply stronger net income, and management commentary pointing to momentum across energy, data center, and military markets. See our latest analysis for American Superconductor. The latest results and guidance arrived after a strong run in the share price, with a 24.09% 7 day share price return and a 12.88% 1 year total shareholder return, suggesting momentum has...

Core Natural Resources, Inc. has reported its fourth-quarter 2025 results, with sales rising to US$1,042.47 million while posting a net loss of US$78.98 million, and the board has declared a US$0.10 per share quarterly dividend payable on March 16, 2026, to shareholders of record on March 2, 2026. The company also completed a share repurchase program totaling 3,088,520 shares for US$224.29 million and issued 2026 sales volume guidance of 85.6 million to 91.4 million tons, offering fresh...

Why Deere is on investors’ radar today Without a single headline event setting things off, Deere (DE) is drawing attention after a strong run in its share price and solid recent financial metrics that have many investors reassessing the stock. See our latest analysis for Deere. The recent move in Deere’s share price, now at US$612.69 after a 24.85% 1 month share price return and 31.25% year to date share price return, sits alongside a 5 year total shareholder return of 109.56%. This suggests...

HCI Group (HCI) has drawn attention after recent share price swings, with the stock showing mixed returns across the past week, month, and past 3 months. This has prompted investors to reassess its current valuation. See our latest analysis for HCI Group. The recent 1-day share price return of 1.22% and 7-day share price return of 5.45% come after a weaker patch, with the 30-day and year-to-date share price returns both around a 10% decline. At the same time, the 1-year total shareholder...

Scorpio Tankers Inc. ( NYSE:STNG ) shares have had a really impressive month, gaining 27% after a shaky period...

If you are wondering whether Nucor’s current share price fairly reflects its underlying worth, you are not alone. This article is designed to help you assess that. Nucor’s stock closed at US$194.42, with returns of 2.4% over 7 days, 17.1% over 30 days, 14.8% year to date, 48.0% over 1 year and 19.4% over 3 years. These moves naturally raise questions about how the valuation stacks up. Recent attention on Nucor has focused on its role in the US materials sector and how investors are thinking...

AT&T (NYSE:T) has partnered with Amazon Web Services and Amazon Leo to modernize parts of the US connectivity infrastructure using cloud and satellite technology. The company has completed its acquisition of Lumen's mass markets fiber business, expanding its fiber and broadband reach to more households. AT&T is also rolling out new offerings, including the amiGO Jr. Phone for children and connected healthcare partnerships that build on its network capabilities. AT&T enters this phase of...

The market seemed underwhelmed by the solid earnings posted by Embecta Corp. ( NASDAQ:EMBC ) recently. We have done...

Palantir Technologies (PLTR) just capped a standout fourth quarter, pairing ambitious 2026 guidance with fresh proof points such as the Airbus renewal and DISA’s authorization of its Federal Cloud Service Forward. See our latest analysis for Palantir Technologies. Despite a string of contract wins and product milestones, including the Airbus renewal and DISA’s green light for PFCS Forward, Palantir’s recent share price momentum has cooled, with a 30 day share price return of a 24.37% decline...

If you are wondering whether KBR's current share price lines up with its underlying worth, you are not alone and this article is here to help you size up that question quickly. KBR closed at US$40.90, with returns of 4.1% decline over 7 days, 7.7% decline over 30 days, a 1.0% gain year to date, and a 22.2% decline over 1 year, while the 5 year return sits at 36.7% and the 3 year return at 18.4% decline. Recent coverage around KBR has focused on its position in the commercial services space...

Halozyme Therapeutics (NasdaqGS:HALO) has acquired three biotech startups as part of a broader push to expand its business. The company highlighted these transactions alongside fresh CEO commentary on how it is approaching M&A. The deals arrive at a time of faster consolidation activity across the biotech sector. Halozyme focuses on drug delivery and biotechnology platforms, and these new acquisitions signal a clear push to widen its reach within the sector. For investors watching biotech,...

Why this management shake up matters for FTAI Aviation FTAI Aviation (FTAI) sits at an interesting crossroads after Jefferies raised its outlook and the board appointed David Moreno as President and Stacy Kuperus as principal operating officer. For you as an investor, these moves connect analyst confidence with leadership that has already been closely involved in the company’s aviation and power related businesses. See our latest analysis for FTAI Aviation. FTAI Aviation’s recent management...

Klaviyo (KVYO) has capped FY 2025 with Q4 revenue of US$350.2 million and basic EPS of US$0.02, while on a trailing twelve month basis the business generated US$1.2 billion of revenue and a net loss of US$31.8 million. The company has seen quarterly revenue move from US$270.2 million in Q4 FY 2024 to US$350.2 million in Q4 FY 2025, and basic EPS shift from a loss of US$0.10 to a small profit of US$0.02 over the same period. This sets up an earnings season story that hinges on how durable this...

In late January 2026, Olema Pharmaceuticals announced the departure of Chief Operating and Financial Officer Shane Kovacs, with CEO Dr. Sean P. Bohen stepping in as interim Principal Financial Officer while the company searches for a new CFO. Ahead of its recent presentation at Guggenheim Securities’ Emerging Outlook: Biotech Summit 2026 in New York, Olema also drew fresh attention from Wall Street as Stifel initiated analyst coverage with a positive view on the company. Next, we’ll examine...

If you are looking at First Merchants and wondering whether the current share price still represents good value, you are not alone. The stock last closed at US$42.05, with returns of 0.5% over the past 7 days, 11.7% over 30 days, 12.1% year to date and a 1% decline over the past year, which may signal changing expectations around its prospects and risk. This article was prompted by Simply Wall St's evergreen coverage of First Merchants, which periodically refreshes to keep valuation and...